Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 45 holding rows worth $3,265,707,000.

Accession
0001654954-22-015172
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 45 entries on the cover page, a total value of $3,265,707,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,265,707,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SANOFI SA SPONSORED ADR80105N105ADR7,500,000$285,150,000thousands by filing date
VIATRIS INC COM92556V106Stock30,000,000$255,600,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock2,250,000$198,405,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,500,000$165,810,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock3,000,000$154,740,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock1,400,000$146,370,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM2,000,000$139,680,000thousands by filing date
Merck & Co.,Inc.58933Y105COM1,500,000$129,180,000thousands by filing datecall
PTC THERAPEUTICS INC69366J200COM2,450,000$122,990,000thousands by filing date
Pfizer Inc.717081103COM2,500,000$109,400,000thousands by filing datecall
SELECT MED HLDGS CORP81619Q105COM4,800,000$106,080,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM500,000$98,400,000thousands by filing date
MYRIAD GENETICS INC62855J104COM5,000,000$95,400,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock2,500,000$89,150,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM2,825,000$88,705,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock1,925,000$85,143,000thousands by filing date
GSK PLC SPONSORED ADR37733W204ADR2,500,000$73,575,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM16,000,000$68,320,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM800,000$67,816,000thousands by filing date
CHANGE HEALTHCARE INC15912K100COM2,325,000$63,914,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR7,500,000$60,525,000thousands by filing date
BIOGEN INC COM09062X103Stock200,000$53,400,000thousands by filing date
INCYTE CORP COM45337C102Stock750,000$49,980,000thousands by filing date
CANO HEALTH INC13781Y103COM5,000,000$43,350,000thousands by filing date
QUIDELORTHO CORP COM219798105Stock600,000$42,888,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock200,000$41,422,000thousands by filing date
Medtronic PlcG5960L103COM500,000$40,375,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM1,415,000$40,115,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR1,000,000$38,020,000thousands by filing datecall
SEAGEN INC81181C104COM250,000$34,208,000thousands by filing date
QUANTERIX CORP74766Q101COMMON STOCK3,000,000$33,060,000thousands by filing date
ZIMVIE INC98888T107COM2,600,000$25,662,000thousands by filing date
NUVASIVE INC670704105COM500,000$21,905,000thousands by filing date
EXELIXIS INC COM30161Q104Stock1,350,000$21,168,000thousands by filing date
PELOTON INTERACTIVE INC70614W100CL A COM3,000,000$20,790,000thousands by filing date
INOGEN INC45780L104COM825,000$20,031,000thousands by filing date
GLAUKOS CORP COM377322102Stock350,000$18,634,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK1,300,000$18,018,000thousands by filing date
ZYMEWORKS INC98985W102COM2,865,000$17,620,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM1,050,000$16,821,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM4,250,000$16,108,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM1,000,000$12,770,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A500,000$12,565,000thousands by filing date
OAK STR HEALTH INC67181A107COM506,000$12,407,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK4,235,000$10,037,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-22-015172this filing2022-11-14acceptance time not in the bulk data set